Quick Takeaways
- Neil Gallagher has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $3,146,138.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Neil Gallagher
- Location
- Waltham, MA
- Summary
- The estimated net worth of Neil Gallagher is at least $3,146,138 dollars as of 02 May 2025. Neil Gallagher is the President, Head of R&D of Syndax Pharmaceuticals Inc and owns shares of Syndax Pharmaceuticals Inc (SNDX) stock worth about $2.94M. Neil Gallagher is the Director of Foghorn Therapeutics Inc. and owns shares of Foghorn Therapeutics Inc. (FHTX) stock worth about $208K.
- Signature
- /s/ Michael LaCascia, Attorney-in-Fact for Neil Gallagher
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Neil Gallagher and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Syndax Pharmaceuticals Inc ($2,938,138).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Neil Gallagher
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | President, Head of R&D | $2,938,138 | 10 Feb 2025 | ||
| FHTX | Foghorn Therapeutics Inc. | Director | $208,000 | 01 May 2025 | ||
| ZYME | Zymeworks Inc. | Director | 10 Dec 2024 |
Insider Transactions Reported by Neil Gallagher:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.